Depression News and Research

Latest Depression News and Research

Merging AI with targeted electrical brain stimulation to improve specific human brain functions

In a pilot human study, researchers from the University of Minnesota Medical School and Massachusetts General Hospital show it is possible to improve specific human brain functions related to self-control and mental flexibility by merging artificial intelligence with targeted electrical brain stimulation.

1 Nov 2021

Factors predicting cognitive symptoms in long COVID

The researchers focused on finding risk factors for long-term symptom occurrence and severity, with special attention to cognitive impairment.

1 Nov 2021

Stanford neuromodulation therapy causes remission in almost 80% of patients with severe depression

A new type of magnetic brain stimulation brought rapid remission to almost 80% of participants with severe depression in a study conducted at the Stanford University School of Medicine.

30 Oct 2021

Researchers receive $9.1 million grant to study resilience in older adults before and during the pandemic

The National Institute on Aging of the National Institutes of Health has awarded researchers at Washington University School of Medicine in St. Louis a five-year, $9.1 million grant to study resilience in older adults before and during the COVID-19 pandemic, as well as the pandemic's cognitive and emotional effects on older adults.

30 Oct 2021

Women in the military face a considerable risk of emotional bullying, sexual harassment and physical assault

Women serving in the UK military face a considerable risk of emotional bullying, sexual harassment and physical assault, which can have a serious and long-lasting impact on their mental health and wellbeing, finds research published online in the journal BMJ Military Health.

30 Oct 2021

Magnus Medical receives FDA's Breakthrough Device Designation for rapid-acting technology to treat major depression

Magnus Medical, Inc., a medical device company, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its individualized, rapid-acting, non-invasive neurostimulation technology designed to treat major depressive disorder (MDD) in people who have not improved sufficiently from antidepressant medication or other treatments.

29 Oct 2021

Review finds great resilience in mental health during during COVID-19 pandemic

Despite a significant but small increase in mental health symptoms early on in the COVID-19 pandemic, overall there was great resilience in mental health during 2020, University of Liverpool researchers have found.

28 Oct 2021

Using fluvoxamine to treat COVID-19 patients reduces the need for prolonged hospitalization, trial shows

The results of a new randomized clinical trial, published in The Lancet Global Health, have demonstrated that using fluvoxamine to treat high-risk outpatients with early-diagnosed COVID-19 reduced the need for prolonged observation in an emergency setting or hospitalization, compared to a control group who received a placebo.

28 Oct 2021

COVID-19 and subacute neuropsychiatric symptoms in adolescents

A new paper discusses neurologic symptoms in children with COVID-19.

27 Oct 2021

Do pre-existing mental disorders and their co-occurrence affect COVID-19 clinical outcomes?

Researchers conducted a study to assess how pre-existing mental disorders are associated with a SARS-CoV-2 infection and how different clusters of mental disorders affect COVID-19 clinical outcomes.

27 Oct 2021

Postpartum women's experience of social restrictions during COVID-19

A new study published on the medRxiv* preprint server has focused on the effect of various social restrictions or lack of social support on women who delivered and raised babies during the pandemic.

27 Oct 2021

Repeated dopamine release in the brain plays a key role in infant social development

Changing levels of the chemical dopamine, a chemical most associated with motivation, may help explain why stressful experiences during infancy can lead to lasting behavioral issues, a new study in rodents shows.

26 Oct 2021

Less physical activity and more screen time impact children's mental health during the pandemic

Few equations are as simple as the findings of a survey measuring the habits of 1,000 children during COVID-19: More physical activity and less screen time led to better mental health.

26 Oct 2021

Wearable technology helps researchers to better understand the underlying health conditions

Wearable technology such as the Apple Watch is allowing researchers to recruit a more diverse group of participants to health and wellness studies, helping them better understand the underlying health conditions they could only dream about glimpsing at before, according to a new three-year landmark observational University of Michigan study.

26 Oct 2021

Mental health determinants during COVID pandemic pregnancies in the U.K.

A new study reports the determinants of the mental state of pregnant women during the pandemic within the U.K. maternity services.

26 Oct 2021

Brain fog in long COVID

A new study explores one troubling manifestation of long COVID, which is the cognitive impairment that follows clinical resolution of COVID-19.

26 Oct 2021

Clinically significant cataract associated with greater mortality risk from vascular causes

Clinically significant cataract is associated with an increased risk of death from vascular causes, such as stroke and heart attack, suggests research published online in the British Journal of Ophthalmology.

26 Oct 2021

NIH invests $74.5 million to advance data science research and spur health discoveries across Africa

The National Institutes of Health is investing about $74.5 million over five years to advance data science, catalyze innovation and spur health discoveries across Africa.

26 Oct 2021

Post COVID-19 affects children as well as adults

A new study presents data on long covid in adults and children, which is becoming a major issue in public health planning.

26 Oct 2021

Stimulant use linked with increased risk of cardiovascular events among older adults in the first month

New research led by Mina Tadrous, Assistant Professor, Leslie Dan Faculty of Pharmacy, University of Toronto shows that use of prescription stimulant medications in older adults increased the risk of a cardiovascular events by 40 per cent within the first thirty days of medication use.

25 Oct 2021

Depression News and Research

Latest Depression News and Research

Merging AI with targeted electrical brain stimulation to improve specific human brain functions

Factors predicting cognitive symptoms in long COVID

Stanford neuromodulation therapy causes remission in almost 80% of patients with severe depression

Researchers receive $9.1 million grant to study resilience in older adults before and during the pandemic

Women in the military face a considerable risk of emotional bullying, sexual harassment and physical assault

Magnus Medical receives FDA's Breakthrough Device Designation for rapid-acting technology to treat major depression

Review finds great resilience in mental health during during COVID-19 pandemic

Using fluvoxamine to treat COVID-19 patients reduces the need for prolonged hospitalization, trial shows

COVID-19 and subacute neuropsychiatric symptoms in adolescents

Do pre-existing mental disorders and their co-occurrence affect COVID-19 clinical outcomes?

Postpartum women's experience of social restrictions during COVID-19

Repeated dopamine release in the brain plays a key role in infant social development

Less physical activity and more screen time impact children's mental health during the pandemic

Wearable technology helps researchers to better understand the underlying health conditions

Mental health determinants during COVID pandemic pregnancies in the U.K.

Brain fog in long COVID

Clinically significant cataract associated with greater mortality risk from vascular causes

NIH invests $74.5 million to advance data science research and spur health discoveries across Africa

Post COVID-19 affects children as well as adults

Stimulant use linked with increased risk of cardiovascular events among older adults in the first month

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Depression News and Research

Latest Depression News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in